These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29872696)

  • 1. Inhibiting breast cancer by targeting the thromboxane A
    Li H; Lee MH; Liu K; Wang T; Song M; Han Y; Yao K; Xie H; Zhu F; Grossmann M; Cleary MP; Chen W; Bode AM; Dong Z
    NPJ Precis Oncol; 2017; 1(1):8. PubMed ID: 29872696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane A2/prostaglandin H2 receptor antagonists. A new therapeutic principle.
    Patscheke H
    Stroke; 1990 Dec; 21(12 Suppl):IV139-42. PubMed ID: 2148033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of thromboxane synthase, TBXAS1 and the thromboxane A2 receptor, TBXA2R, in human breast cancer.
    Watkins G; Douglas-Jones A; Mansel RE; Jiang WG
    Int Semin Surg Oncol; 2005 Oct; 2():23. PubMed ID: 16250911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin suppresses breast cancer metastasis to lung by targeting anoikis resistance.
    Xu R; Yan Y; Zheng X; Zhang H; Chen W; Li H; Dong Z
    Carcinogenesis; 2022 Mar; 43(2):104-114. PubMed ID: 34958360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the COX1/2-Driven thromboxane A2 pathway suppresses Barrett's esophagus and esophageal adenocarcinoma development.
    Zhang T; Wang Q; Ma WY; Wang K; Chang X; Johnson ML; Bai R; Bode AM; Foster NR; Falk GW; Limburg PJ; Iyer PG; Dong Z
    EBioMedicine; 2019 Nov; 49():145-156. PubMed ID: 31707149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
    J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of nitric oxide deficiency on primary tumour growth, pulmonary metastasis and prostacyclin/thromboxane A
    Kij A; Kus K; Smeda M; Zakrzewska A; Proniewski B; Matyjaszczyk K; Jasztal A; Stojak M; Walczak M; Chlopicki S
    J Physiol Pharmacol; 2018 Dec; 69(6):. PubMed ID: 30802213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet properties of Pim kinase inhibition are mediated through disruption of thromboxane A2 receptor signaling.
    Unsworth AJ; Bye AP; Sage T; Gaspar RS; Eaton N; Drew C; Stainer A; Kriek N; Volberding PJ; Hutchinson JL; Riley R; Jones S; Mundell SJ; Cui W; Falet H; Gibbins JM
    Haematologica; 2021 Jul; 106(7):1968-1978. PubMed ID: 32467143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice.
    Ma Z; Parris AB; Xiao Z; Howard EW; Kosanke SD; Feng X; Yang X
    J Exp Clin Cancer Res; 2017 Jan; 36(1):6. PubMed ID: 28061785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of integrin α3β1 promotes the progression of HER2-driven breast cancer in vivo.
    Ramovs V; Secades P; Song JY; Thijssen B; Kreft M; Sonnenberg A
    Breast Cancer Res; 2019 May; 21(1):63. PubMed ID: 31101121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane A2 receptor α promotes tumor growth through an autoregulatory feedback pathway.
    Huang RY; Li MY; Ng CS; Wan IY; Kong AW; Du J; Long X; Underwood MJ; Mok TS; Chen GG
    J Mol Cell Biol; 2013 Dec; 5(6):380-90. PubMed ID: 24115277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting the usefulness of thromboxane-A2 modulation in the treatment of bronchoconstriction in asthma.
    Hernandez JM; Janssen LJ
    Can J Physiol Pharmacol; 2015 Feb; 93(2):111-7. PubMed ID: 25581104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genistein Ameliorates Non-alcoholic Fatty Liver Disease by Targeting the Thromboxane A
    Wang W; Chen J; Mao J; Li H; Wang M; Zhang H; Li H; Chen W
    J Agric Food Chem; 2018 Jun; 66(23):5853-5859. PubMed ID: 29771124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role and Regulation of Thromboxane A
    Ashton AW; Zhang Y; Cazzolli R; Honn KV
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary arteries.
    Vandeplassche G; Hemans C; Van de Water A; Xhonneux R; Wouters L; Van Ammel K; De Clerck F
    Circ Res; 1991 Aug; 69(2):313-24. PubMed ID: 1830517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glibenclamide inhibits thromboxane A2-induced contraction in human internal mammary artery and saphenous vein.
    Stanke F; Cracowski JL; Chavanon O; Magne JL; Blin D; Bessard G; Devillier P
    Eur J Pharmacol; 1998 Jan; 341(1):65-71. PubMed ID: 9489857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100a4 upregulation in Pik3caH1047R;Trp53R270H;MMTV-Cre-driven mammary tumors promotes metastasis.
    Yuan W; Goldstein LD; Durinck S; Chen YJ; Nguyen TT; Kljavin NM; Sokol ES; Stawiski EW; Haley B; Ziai J; Modrusan Z; Seshagiri S
    Breast Cancer Res; 2019 Dec; 21(1):152. PubMed ID: 31881983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of prostaglandin E2 and thromboxane A2 synthesis and suppression of PHA-stimulated peripheral blood mononuclear leucocytes.
    Awara W; Hillier K; Jones D
    Immunology; 1986 Dec; 59(4):557-62. PubMed ID: 3468061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor antagonist, versus aspirin as adjunct to thrombolysis in patients with acute myocardial infarction. The Ridogrel Versus Aspirin Patency Trial (RAPT).
    Circulation; 1994 Feb; 89(2):588-95. PubMed ID: 8313547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.